View Older Stories View More Recent Stories

Sep 27, 2018 07:30AM Akrevia Therapeutics Launches with $30M Series A Financing Led by F-Prime Capital Partners and Atlas Venture
Sep 17, 2018 03:00AM Virion Appoints Vanessa King as President & CEO and Isabel Najera as CSO
Sep 11, 2018 07:00AM Andrew Cheng, MD, PhD Joins Akero Therapeutics as President and Chief Executive Officer
Aug 2, 2018 04:30PM Navitor Pharmaceuticals Appoints Thomas E. Hughes, Ph.D. as Chief Executive Officer
Jul 31, 2018 08:00AM Generation Bio Appoints Charles Rowland to its Board of Directors
Jul 31, 2018 06:46AM Form 13F-HR Atlas Venture Associates For: Jun 30
Jul 27, 2018 08:00AM Life Science Executives and Investors Connect with Biotech Startups at BioPharm America™ Global Partnering Event this September
Jul 26, 2018 05:26PM Form 4 Replimune Group, Inc. For: Jul 24 Filed by: Atlas Venture Associates X, LLC
Jul 23, 2018 07:00AM Disarm Therapeutics Presents Data Demonstrating the Protective Effect of SARM1 Deletion on Axonal Degeneration
Jul 19, 2018 09:19PM Form 3 Replimune Group, Inc. For: Jul 19 Filed by: Atlas Venture Fund X, L.P.
Jul 19, 2018 07:30AM IFM Therapeutics, LLC Launches Subsidiary, IFM Tre, with $31 Million Series A Financing to Develop NLRP3 Antagonists for Inflammatory Diseases
Jul 17, 2018 07:00AM HotSpot Therapeutics Completes $45 Million Series A Financing to Advance New Approach to Allosteric Drug Discovery
Jul 3, 2018 06:45PM Form 4 Translate Bio, Inc. For: Jul 02 Filed by: Atlas Venture Fund VIII, L.P.
Jul 2, 2018 04:02PM Form 4 ZAFGEN, INC. For: Jun 29 Filed by: Atlas Venture Associates VII, L.P.
Jun 27, 2018 06:34PM Form 3 Translate Bio, Inc. For: Jun 27 Filed by: Atlas Venture Associates VIII, L.P.
Jun 27, 2018 04:37PM Form 4 Magenta Therapeutics, For: Jun 25 Filed by: ATLAS VENTURE ASSOCIATES X, L.P.
Jun 25, 2018 06:23PM Form 4 AVROBIO, Inc. For: Jun 25 Filed by: ATLAS VENTURE ASSOCIATES X, L.P.
Jun 25, 2018 07:00AM Akero Therapeutics Closes $65 Million Series A Financing to Advance New Treatments for Serious Metabolic Diseases
Jun 20, 2018 08:45PM Form 3 Magenta Therapeutics, For: Jun 20 Filed by: Atlas Venture Fund X, L.P.
Jun 20, 2018 08:07PM Form 3 AVROBIO, Inc. For: Jun 20 Filed by: Atlas Venture Fund X, L.P.
Jun 7, 2018 08:00AM Generation Bio Appoints Jeff Jonas M.D. to its Board of Directors
Jun 5, 2018 07:00AM Atlas Venture Announces Andrea Armstrong Joins as Chief Talent Officer
May 31, 2018 11:53AM Harvard Business School Names 2018-2019 Blavatnik Fellows in Life Science Entrepreneurship
May 31, 2018 07:00AM BioPharm America™ Once Again Offers Top Quality Opportunities for Networking with Global Life Science Executives This September
May 18, 2018 05:00AM Accent Therapeutics Announces Company Launch with $40 Million Series A Financing for Novel, Precision Cancer Treatments Targeting RNA-Modifying Proteins
May 17, 2018 08:30AM Navitor Pharmaceuticals to Present at UBS Global Healthcare Conference
May 16, 2018 07:30AM Plastiq Secures $27 Million in New Funding Round to Accelerate Growth of Payments Platform for Small Business
May 15, 2018 05:00AM Rodin Therapeutics Expands Leadership Team, Adding Extensive Experience in Clinical and Business Development
May 10, 2018 09:11PM Form 4 Carbon Black, Inc. For: May 08 Filed by: ATLAS VENTURE ENTREPRENEURS FUND VI LP
May 8, 2018 09:54AM Form 13F-HR Atlas Venture Associates For: Mar 31
May 8, 2018 08:00AM Generation Bio Expands Leadership Team with Appointment of Sara Den Besten as Head of Human Resources
May 4, 2018 10:00AM Science 2 Startup Symposium Convened Over 230 Academic Researchers, Venture Capitalists, Entrepreneurs, and Pharmaceutical Executives, Creating Connections that can Advance Scientific Innovation and E
May 3, 2018 09:52PM Form 3 Carbon Black, Inc. For: May 03 Filed by: ATLAS VENTURE ENTREPRENEURS FUND VI LP
May 1, 2018 08:00AM Obsidian to Present Data on Regulated Cytokine Programs at the Upcoming American Society of Gene and Cell Therapy (ASGCT) 21st Annual Meeting
Apr 23, 2018 04:19PM Form 4 Atlas Venture Associates For: Apr 23 Filed by: Surface Oncology, Inc.
Apr 18, 2018 04:56PM Form 3 Atlas Venture Associates For: Apr 18 Filed by: Surface Oncology, Inc.
Apr 17, 2018 08:00AM Obsidian Therapeutics Presents Preclinical Data from Regulated Cytokine Programs that Enable CAR-T Therapies with Controllable Functions
Apr 12, 2018 09:00AM Atlas Venture, F-Prime Capital Partners and SV Health Investors to Host Symposium Featuring Therapeutics Startup Ideas From World’s Top Academic Research Institutions
Apr 9, 2018 09:30AM Be The Match BioTherapies Strengthens Partnership with Magenta Therapeutics
Apr 9, 2018 09:00AM Magenta Therapeutics Secures $52 Million in Series C Financing
Apr 9, 2018 08:00AM Generation Bio Strengthens Leadership Team with Appointment of Will McCarthy as Chief Business Officer and Jennifer Elliott, Ph.D., J.D., as Head of Legal Affairs and Intellectual Property
Apr 6, 2018 10:05AM Magenta Therapeutics Appoints Amy Ronneberg, President of Be The Match BioTherapies, to Board of Directors
Apr 5, 2018 08:30AM Magenta Therapeutics Announces First Patient Transplanted with MGTA-456 in Phase 2 Study in Inherited Metabolic Disorders
Apr 3, 2018 05:18PM Form 4 Atlas Venture Associates For: Apr 03 Filed by: Unum Therapeutics Inc.
Apr 3, 2018 08:30AM Magenta Therapeutics Announces Departure of Chief Operating Officer Bastiano Sanna, Ph.D.
Mar 28, 2018 09:11PM Form 3 Unum Therapeutics, Inc. For: Mar 28 Filed by: Atlas Venture Associates IX, L.P.
Mar 20, 2018 07:00AM Surface Oncology Announces First Patient Dosed in Phase 1 Clinical Trial of SRF231
Mar 19, 2018 08:30AM Obsidian Therapeutics to Present at Upcoming Investor Conferences
Mar 15, 2018 08:00AM Obsidian to Present Data on its Destabilizing Domain Technology and Product Programs at the Upcoming 2018 American Association for Cancer Research (AACR) Annual Meeting
Mar 14, 2018 04:31PM Form SC 13D Spero Therapeutics, Inc. Filed by: Atlas Venture Fund X, L.P.
View More Recent Stories View Older Stories